Clinical Trials
All Clinical Trials - Page 1 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07382375N/ANot Yet Recruiting
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Thymosin-Alpha-1
- NCT07430332Phase 2Not Yet Recruiting
GLP-1 RA for Stage 1 Type 1 Diabetes
Semaglutide
- NCT07754045Phase 2Not Yet Recruiting
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
Semaglutide
- NCT07731256Phase 2Not Yet Recruiting
Semaglutide for Low Back Pain
Semaglutide
- NCT07787936N/ANot Yet Recruiting
GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry
Tirzepatide
- NCT06558422Phase 1Not Yet Recruiting
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Octreotide
- NCT07706361N/ANot Yet Recruiting
Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults
GHK-Cu
- NCT06180616Phase 2Not Yet Recruiting
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
Tirzepatide
- NCT07790861Phase 3Not Yet Recruiting
A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
Orforglipron
- NCT07468552Phase 2Not Yet Recruiting
Trial of Tirzepatide for the Treatment of Cannabis Use Disorder
Tirzepatide
- NCT07027969Phase 4Not Yet Recruiting
Metabolic Surgery for Atrial Fibrillation Elimination
Tirzepatide
- NCT07349641Phase 2Not Yet Recruiting
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
Tirzepatide
- NCT07609160N/ANot Yet Recruiting
Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals
Tirzepatide
- NCT06546384N/ANot Yet Recruiting
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
Semaglutide
- NCT07781150Phase 2Not Yet Recruiting
Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer
Mazdutide
- NCT07729332Phase 4Not Yet Recruiting
Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
Orforglipron
- NCT07772960Phase 1Not Yet Recruiting
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
Semaglutide
- NCT06977438Phase 4Not Yet Recruiting
GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward
Semaglutide
- NCT07739537Phase 4Not Yet Recruiting
PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
Orforglipron
- NCT07782359Phase 1Not Yet Recruiting
Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
Tirzepatide
- NCT07758231Phase 1Not Yet Recruiting
Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics
Tirzepatide
- NCT07677891Phase 2Not Yet Recruiting
Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus
Dulaglutide
- NCT07767552N/ANot Yet Recruiting
Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial
Mazdutide
- NCT07589686Phase 2Not Yet Recruiting
A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight
Petrelintide
- NCT07668414Phase 3Not Yet Recruiting
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Semaglutide
- NCT07340619Phase 2Not Yet Recruiting
Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.
Gonadorelin
- NCT07734870Phase 2Not Yet Recruiting
Tirzepatide for Treatment of CCCA
Tirzepatide
- NCT07713992N/ANot Yet Recruiting
Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide
Semaglutide
- NCT07728812N/ANot Yet Recruiting
Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy
Tirzepatide
- NCT07715929Phase 4Not Yet Recruiting
Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients
Tirzepatide
- NCT07485062Phase 4Not Yet Recruiting
Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes
Semaglutide
- NCT07478653N/ANot Yet Recruiting
MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease
Semaglutide
- NCT07769047Phase 4Not Yet Recruiting
Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors
Semaglutide
- NCT07768813Phase 1Not Yet Recruiting
A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity
Survodutide
- NCT07718126Phase 2/Phase 3Not Yet Recruiting
Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)
Mazdutide
- NCT07775846Phase 4Not Yet Recruiting
QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy
Mazdutide
- NCT07657676Phase 4Not Yet Recruiting
Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
Mazdutide
- NCT07793019Phase 1Not Yet Recruiting
IBI3042 Study in Healthy Participants and Overweight or Obese Participants
Orforglipron
- NCT07756359Phase 4Not Yet Recruiting
Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
Tirzepatide
- NCT07628985Phase 3Not Yet Recruiting
BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes
Semaglutide
- NCT07622810Phase 3Not Yet Recruiting
BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity
Semaglutide
- NCT07668336Phase 3Not Yet Recruiting
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Dulaglutide
- NCT07780344N/ANot Yet Recruiting
MRI Parameters as Biomarkers in Cystic Fibrosis (FEMPTO)
Linaclotide
- NCT07783282Phase 1Not Yet Recruiting
A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer
Gonadorelin
- NCT07755956Phase 1Not Yet Recruiting
Phase Ia Trial of HHK001 Compared With Enantone in Patients With Endometriosis
Gonadorelin
- NCT06881888Phase 1Not Yet Recruiting
Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
Octreotide
- NCT07780721Phase 2Not Yet Recruiting
Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer
Thymosin-Alpha-1
- NCT07765160Phase 1Not Yet Recruiting
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants
Mazdutide
- NCT07747805Phase 2Not Yet Recruiting
GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
Tirzepatide
- NCT07357740Phase 2Withdrawn
A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes
Semaglutide